FDA Gives Green Light to Zykadia as First-line Therapy for ALK-positive NSCLC
News
The U.S. Food and Drug Administration has approved Norvartis‘ Zykadia (ceritinib) to be used as first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic ... Read more